Currently, there are four main treatments propelling this market forward: Ozempic and Wegovy (semaglutide: a GLP-1 agonist, developed by Novo Nordisk) Mounjaro and Zepbound (tirzepatide: a dual agonist targeting both GLP-1 and GIP (Gastric inhibitory polypeptide) receptors, developed by Eli Lilly) These medications are administered subcutaneously with the assistance of injection pens
Common symptoms include dizziness, lightheadedness, blurred vision, fatigue, nausea, difficulty concentrating, and in severe cases, syncope (fainting)
Factors influencing this decision include: GI sensitivity Blood sugar control needs Medication half-life I personally have seen patients switch without the need for a washout period except for on rare occasions when they experience severe side effects from semaglutide Potential Benefits of Switching to Tirzepatide Potential Benefits of Switching to Tirzepatide Switching from semaglutide to tirzepatide may offer several potential benefits, especially for individuals who havent achieved their target weight or glycemic control
Semaglutide studies showed up to 40% of total weight lost came from lean mass in some participants
Work with a Registered Dietitian If youre struggling to manage side effects, meet your nutritional needs, or adapt your diet to your health conditions, working with a registered dietitian can be invaluable
By consistently integrating a healthy diet and regular physical activity into your daily routine, you bolster your chances of preserving the weight loss achieved during the medication period and fortify your overall health